These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37486516)

  • 1. The CRISPR/Cas System in Human Cancer.
    Bonamino MH; Correia EM
    Adv Exp Med Biol; 2023; 1429():59-71. PubMed ID: 37486516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy.
    Sarkar E; Khan A
    Cancer Treat Res Commun; 2021; 27():100289. PubMed ID: 33667951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR technology for immuno-oncology applications.
    Wang J; Balan V; Marincola F
    Methods Enzymol; 2020; 635():251-266. PubMed ID: 32122549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.
    Bhatia S; Pooja ; Yadav SK
    Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.
    Yang X; Zhang B
    Funct Integr Genomics; 2023 May; 23(2):182. PubMed ID: 37231285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 for the Clinician: Current uses of gene editing and applications for new therapeutics in oncology.
    Boland J; Nedelcu E
    Perm J; 2020 Dec; 24():1-3. PubMed ID: 33482972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases.
    Rahman S; Datta M; Kim J; Jan AT
    Semin Cell Dev Biol; 2019 Dec; 96():22-31. PubMed ID: 31102655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of CRISPR-mediated genome engineering in cancer research.
    Sayin VI; Papagiannakopoulos T
    Cancer Lett; 2017 Feb; 387():10-17. PubMed ID: 27000990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research.
    Pandey PK; Quilichini TD; Vaid N; Gao P; Xiang D; Datla R
    Semin Cell Dev Biol; 2019 Dec; 96():107-114. PubMed ID: 31022459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy.
    Aziz A; Rehman U; Sheikh A; Abourehab MAS; Kesharwani P
    J Biomater Sci Polym Ed; 2023 Feb; 34(3):398-418. PubMed ID: 36083788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice.
    van der Weyden L; Jonkers J; Adams DJ
    Curr Opin Genet Dev; 2021 Feb; 66():57-62. PubMed ID: 33429291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Transgenic Core Facility's Experience in Genome Editing Revolution.
    Yuan CL; Hu YC
    Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research.
    Li ZH; Wang J; Xu JP; Wang J; Yang X
    Mil Med Res; 2023 Mar; 10(1):12. PubMed ID: 36895064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas System: The Current and Emerging Translational Landscape.
    Bhokisham N; Laudermilch E; Traeger LL; Bonilla TD; Ruiz-Estevez M; Becker JR
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
    Dey A; Nandy S
    Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.